Dr. Ram A. Pathak, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 513
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
FL license ME120400 · NC license 2017-00795
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mayo Clinic Jacksonville, FL
Medical groups
- Mayo Clinic Jacksonville (1,615 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 513
- Services billed
- 1,569
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 45-59 minutes | 193 | 193 |
| Established patient office or other outpatient visit, 30-39 minutes | 174 | 125 |
| Established patient office or other outpatient visit, 20-29 minutes | 69 | 52 |
| Biopsy of prostate gland | 51 | 50 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 48 | 48 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 46 | 46 |
| Injection, garamycin, gentamicin, up to 80 mg | 35 | 28 |
| Ultrasound measurement of bladder capacity after voiding | 32 | 27 |
| Diagnostic exam of bladder and urethra using an endoscope | 29 | 22 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 26 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 14 companies reported 28 payments worth $6,238 in total to this clinician.
| Profound Medical Corp. | $3,852 |
|---|---|
| Angiodynamics, Inc. | $800 |
| Intuitive Surgical, Inc. | $421 |
| Cook Medical LLC | $207 |
| Bioprotect Medical, Inc. | $207 |
| Teleflex LLC | $134 |
| Calyxo, Inc. | $124 |
| Endo USA, Inc. | $111 |
| Food and Beverage | $3,638 |
|---|---|
| Travel and Lodging | $2,600 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Profound Medical Corp. Feb 24, 2025 | Travel and Lodging Tulsa-Pro · Oncology · travel to Las Vegas, NV | $964 |
| Profound Medical Corp. Sep 15, 2025 | Travel and Lodging Tulsa-Pro · Oncology · travel to Las Vegas, NV | $837 |
| Angiodynamics, Inc. Aug 20, 2025 | Travel and Lodging NANOKNIFE · OS · travel to FORT WORTH, TX · in-kind | $554 |
| Angiodynamics, Inc. Oct 8, 2025 | Travel and Lodging NANOKNIFE · OS · travel to PHOENIX, AZ | $239 |
| Angiodynamics, Inc. Aug 20, 2025 | Travel and Lodging NANOKNIFE · OS · travel to PHOENIX, AZ · in-kind | $6.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $55,097 in research payments for these studies, mostly to the institutions running them.
- Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Blue Earth Diagnostics · Completed · NCT06604442 - Safe Omission of Pelvic Lymph Node Dissection during Radical Prostatectomy (SOuND Protocol)
Blue Earth Diagnostics
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.